Manifestaciones hepatopancreáticas en síndrome hemolítico urémico atípico

Diana Vargas, Mariangel Castillo Arteaga, María Sánchez-Tordecilla

Producción: Contribución a una revistaArtículorevisión exhaustiva

Resumen

Introduction: Atypical hemolytic uremic syndrome is a severe and orphan disease, in its atypical variety courses with extrarenal clinical manifestations. The presence of gastrointestinal compromise is infrequent, but the prognosis is unfavorable, since they have more relapses and higher mortality. Therefore, it is important that physicians are trained in recognizing the rare manifestations of this pathology, in order to improve the outcome in these patients. Purpose: This case illustrates a unique case in terms of symptoms and etiology not previously described. Case presentation: We report the case of an 8-year-old male who presented with fever, jaundice, abdominal and lumbar pain, diarrhea, hematemesis, and hematuria. Atypical hemolytic uremic syndrome was diagnosed. He presented clinical deterioration with multiple organ involvement, documenting high blood pressure and acute kidney injury, who received management with crystalloids and diuretics without improvement, requiring renal replacement therapy and multiple transfusional support. However, there was still no clinical improvement, so the start of recombinant humanized IgG monoclonal antibody was indicated, with satisfactory outcomes. Discussion and conclusions: This case is a clear example that extrarenal and multi-organ involvement can be the main manifestation of this disease, so it is important that clinicians are aware of the clinical course that may develop a patient with atypical presentations, in order to avoid diagnostic and therapeutic delays. Likewise, the etiological approach is important in order to provide an accurate prognosis to the patient and his family.

Título traducido de la contribuciónHepatopancreatic manifestations in atypical hemolytic uremic syndrome
Idioma originalEspañol
Número de artículoe595
PublicaciónRevista Colombiana de Nefrologia
Volumen9
N.º3
DOI
EstadoPublicada - 07 oct. 2022

Palabras clave

  • atypical hemolytic uremic syndrome
  • eculizumab
  • hepatitis
  • mutation
  • pancreatitis

Huella

Profundice en los temas de investigación de 'Manifestaciones hepatopancreáticas en síndrome hemolítico urémico atípico'. En conjunto forman una huella única.

Citar esto